Ratings Brown-Forman Corporation Nyse

Equities

BF.A

US1156371007

Market Closed - Nyse 04:00:01 2024-07-10 pm EDT 5-day change 1st Jan Change
43.61 USD +2.49% Intraday chart for Brown-Forman Corporation +2.08% -26.82%

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The opinion of analysts covering the stock has improved over the past four months.
  • Consensus analysts have strongly revised their opinion of the company over the past 12 months.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The firm trades with high earnings multiples: 22.98 times its 2025 earnings per share.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The company is highly valued given the cash flows generated by its activity.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Distillers & Wineries

1st Jan change Capi. Investor Rating ESG Refinitiv
-26.82% 20.32B -
-11.01% 71.36B
A-
-18.62% 34.63B
C+
-7.62% 8.57B
B
-12.04% 4.95B
B-
-20.16% 3.28B -
+0.50% 2.67B
C
-28.58% 1.55B
C+
-3.44% 1.52B
C-
-9.60% 1.33B
B-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. BF.B Stock
  4. BF.A Stock
  5. Ratings Brown-Forman Corporation